BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21550658)

  • 1. Polymorphism of the thymidylate synthase gene and risk of relapse in childhood ALL.
    Pietrzyk JJ; Bik-Multanowski M; Skoczen S; Kowalczyk J; Balwierz W; AlicjaChybicka ; Matysiak M; Szczepanski T; Balcerska A; Bodalski J; Krawczuk-Rybak M; Wysocki M; Sobol G; Wachowiak J
    Leuk Res; 2011 Nov; 35(11):1464-6. PubMed ID: 21550658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.
    Lauten M; Asgedom G; Welte K; Schrappe M; Stanulla M
    Haematologica; 2003 Mar; 88(3):353-4. PubMed ID: 12651279
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population.
    Nazki FH; Masood A; Banday MA; Bhat A; Ganai BA
    Genet Mol Res; 2012 Apr; 11(2):906-17. PubMed ID: 22576918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene.
    Pietrzyk JJ; Bik-Multanowski M; Balwierz W; Skoczen S; Wojcik D; Chybicka A; Sikorska-Fic B; Matysiak M; Szczepanski T; Sonta-Jakimczyk D; Ploszynska A; Balcerska A; Mycko K; Bodalski J; Krawczuk-Rybak M; Kowalczyk J; Koltan A; Sobol G; Derwich K; Kwinta P
    Pediatr Blood Cancer; 2009 Mar; 52(3):364-8. PubMed ID: 18989887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.
    Giovannetti E; Ugrasena DG; Supriyadi E; Vroling L; Azzarello A; de Lange D; Peters GJ; Veerman AJ; Cloos J
    Leuk Res; 2008 Jan; 32(1):19-24. PubMed ID: 17395259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
    Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
    Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis.
    Krajinovic M; Costea I; Primeau M; Dulucq S; Moghrabi A
    Pharmacogenomics J; 2005; 5(6):374-80. PubMed ID: 16130010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of thymidylate synthase 5'-UTR 28bp tandem repeat and serine hydroxymethyltransfarase C1420T polymorphisms with susceptibility to acute leukemia.
    Dunna NR; Naushad SM; Vuree S; Anuradha C; Sailaja K; Surekha D; Rao DR; Vishnupriya S
    Asian Pac J Cancer Prev; 2014; 15(4):1719-23. PubMed ID: 24641398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
    Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia.
    Kim NK; Chong SY; Jang MJ; Hong SH; Kim HS; Cho EK; Lee JA; Ahn MJ; Kim CS; Oh D
    Anticancer Res; 2006; 26(4B):2879-81. PubMed ID: 16886608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia.
    Krajinovic M; Costea I; Chiasson S
    Lancet; 2002 Mar; 359(9311):1033-4. PubMed ID: 11937185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the gamma-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico.
    Organista-Nava J; Gómez-Gómez Y; Saavedra-Herrera MV; Rivera-Ramírez AB; Terán-Porcayo MA; Alarcón-Romero Ldel C; Illades-Aguiar B; Leyva-Vázquez MA
    Leuk Res; 2010 Jun; 34(6):728-32. PubMed ID: 20197200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil.
    Iacopetta B; Grieu F; Joseph D; Elsaleh H
    Br J Cancer; 2001 Sep; 85(6):827-30. PubMed ID: 11556832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia.
    Canalle R; Silveira VS; Scrideli CA; Queiroz RG; Lopes LF; Tone LG
    Leuk Lymphoma; 2011 Jun; 52(6):1118-26. PubMed ID: 21463130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the effect of 3 glucocorticoid receptor gene polymorphisms on risk of relapse in 100 Iranian children with acute lymphoblastic leukemia: a case-control study.
    Namazi S; Zareifar S; Monabati A; Ansari S; Karimzadeh I
    Clin Ther; 2011 Mar; 33(3):280-90. PubMed ID: 21497906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of DNA topoisomerase IIalpha mRNA predicts the treatment response of relapsed acute leukemic patients.
    Wang YH; Takanashi M; Tsuji K; Tanaka N; Shiseki M; Mori N; Motoji T
    Leuk Res; 2009 Jul; 33(7):902-7. PubMed ID: 19185918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymidylate synthase gene promoter polymorphism in patients with advanced head and neck cancer treated by radio- and 5-fluorouracil chemotherapy].
    Kiss-László Z; Nagy B; Thurzó L; Szabó J
    Magy Onkol; 2006; 50(1):33-7. PubMed ID: 16617381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.